# Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars

> **NCT03050749** · NA · COMPLETED · sponsor: **Croma-Pharma GmbH** · enrollment: 56 (actual)

## Conditions studied

- Facial Lipoatrophy
- Morphological Asymmetry of the Face
- Debilitating Scars

## Interventions

- **DEVICE:** Princess® VOLUME

## Key facts

- **NCT ID:** NCT03050749
- **Lead sponsor:** Croma-Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-20
- **Primary completion:** 2017-10-18
- **Final completion:** 2018-03-06
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03050749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03050749, "Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03050749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*